Chemotherapy of trypanosomiasis: the potentiation of melarsoprol by concurrent difluoromethylornithine (DFMO) treatment.
Jennings
F W
FW
Department of Veterinary Parasitology, University of Glasgow, UK.
D000818:Animals; D001152:Arsenicals / Q000627:therapeutic use*; D014355:Chagas Disease / Q000188:drug therapy*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D000518:Eflornithine / Q000627:therapeutic use*; D008549:Melarsoprol / Q000627:therapeutic use*; D051379:Mice; D014346:Trypanosoma brucei brucei
D001152:Arsenicals; D008549:Melarsoprol; D000518:Eflornithine